2861 Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC). (September 2015) - Siano, M.; Molinari, F.; Martin, V.; Mach, N.; Früh, M.; Crippa, S.; Ghielmini, M.; Frattini, M.; Espeli, V.